CALCIUM D3 STADA 1000 mg/880 I.E. Jumper tablets, 120 pcs

Instructions for use for CALCIUM D3 STADA 1000 mg/880 I.E. Jumper tablets, 120 pcs

Detailed instructions for CALCIUM D3 STADA 1000 mg/880 I.E. Jumper tablets, 120 pcs

Field of use

Calcium D3 STADA® 1000 mg/880 I.E. effervescent tablets, a strong duo in osteoporosis, with a pleasant orange taste.

• 1. The combination of calcium and D3 increases the absorption of the calcium in the intestine
• 2. Vitamin D3 increases the installation of calcium into the bones
• 3. Breath tablets with a pleasant orange taste

Bone mineral meets sun vitamin.
The mineral calcium is responsible for the structure of strong bones and is therefore of fundamental importance for the body. Support for the calcium balance can become particularly important for women. In addition, about every third woman develops osteoporosis (bone loss), the treatment of which can be supported by calcium during the menopause.

Calcium D3 STADA® - For supporting treatment of osteoporosis

• The combination of calcium and vitamin D3 increases the absorption of the calcium in the intestine
• Bridalsetable with a pleasant orange taste

This is how Calcium D3 STADA®
A balanced calcium balance is a prerequisite for healthy bones. Calcium can treat diseases such as B. osteoporosis (bone loss). Osteoporosis is a widespread disease that develops in about every third woman during menopause. Men are much less affected. Hormone changes play an important role because estrogens (female sex hormones) counteract bone loss.
The combination with vitamin D3 increases the absorption of the calcium in the intestine and the mirror of the parathormone is reduced. Low vitamin D3 serum mirrors can occur especially in winter and in old age.

Common questions & Answers

What do I do if I forgot Calcium D3 STADA®?
Do not take the twice the amount after a forgotten single dose, but remain with your income.

Can Calcium D3 STADA® be taken during pregnancy?
During pregnancy, Calcium D3 STADA® should only be taken by the doctor after strict benefit-risk assessment and only dosed as it is absolutely necessary to fix the defect. An overdose of vitamin D3 should be avoided.

Active ingredients / ingredients / ingredients

Calcium D3 STADA 1000mg/880 international units (pack size: 120 pc) contains:

The active ingredients are calcium carbonate and cholecalciferol.

1 effervescent tablet contains 2500 mg calcium carbonate according to 1000 mg calcium and 22 μg cholecalciferol according to 880 I.E. vitamin D3.

The other components are: citronic acid, gelatin, lactose-monohydrate, macrogol 6000, cornstarch, sodium cyclamate, sodium hydrogen carbonate, orange saft aroma, povidon K 25, saccharin-sodium, Simeticon emulsion (consisting of: dimetic, methyl cellulose ) ] Soy oil (Ph. EUR.), Sucrose, All-Rac-Alpha-Tocopherol.

What Calcium D3 STADA® looks like and content of the package
White to almost white, round, flat effervescent tablet with typical orange smell. Calcium D3 STADA® is available in packs with 120 effervescent tablets.

Contradictions

In the case of known hypersensitivity to one of the ingredients, this product should not be used.

dosage

Application recommendation of Calcium D3 STADA 1000mg/880 International units (package size: 120 pc):

It is simple: it is recommended to take a brew tablet once a day for a meal. The effervescent tablet is taken up in a glass of water. The duration of the intake depends on the order of the doctor.

Taking

• The effervescent tablets are taken up in a glass of water (200 ml).
• You can take the medicine for eating or between meals.

 

Patient information

 

• When can you only take the medicine after consultation with your doctor?
  • if the kidney stones and kidney calcification are tended to form
  • with limited kidney function
  • with humiliated phosphate concentration in the blood (hypophosphatemia)
• Also ask your doctor for advice if kidney stones containing calcium in your family have occurred.
• The medicine should not be taken in pseudohypoparathyroidism (disturbance of the parathormone household), since the vitamin D requirement can be reduced by the phases of normal vitamin D sensitivity, with the risk of long overdose. For this purpose, more controllable active ingredients with vitamin D activity are available.
• Particular caution when taking the drug is required:
  • By taking the drug increases, the excretion of calcium in the urine increases. In the first few months after revenuethis increases the tendency to precipitate calcium salts and, under certain circumstances, to form stone in the kidney and urine bladder. This can be avoided by a ample supply of liquid.
  • In the case of renal failure, the medicine should only be used in the blood and urine while monitoring calcium and phosphate concentrations.
  • During long -term treatment with the medicine, the calcium levels in the blood and urine should be monitored and the kidney function should be checked by measuring the serum creatinine. This review is particularly important in older patients and at the same time treatment with heart glycosides (medicines to promote the function of the cardiac muscles) or diuretics (medicines to promote urine excretion). In the case of hypercalcemia (increased calcium concentration in the blood) or signs of reduced kidney function, the dose must be reduced or the treatment is interrupted. It is advisable to reduce the dose or to interrupt the treatment if the calcium content in the urine is 7.5 mmol/24 hours (300 mg/24 hours).
  • If other medicinal products containing vitamin D are prescribed, the dose of vitamin D must be taken into account in the medicine. Additional administration of vitamin D or calcium should only be carried out under medical monitoring. In such cases, the calcium levels in the blood and urine must be monitored.
  • In patients with disturbed excretion of calcium and phosphate, the medicine should only be used with special caution in the case of treatment with benzothiadiazin derivatives (medicinal products for promoting urine excretion) and for immobilized patients [Risiko der Hypercalcämie (erhöhte Calciumkonzentration im Blut) und Hypercalciurie (erhöhte Calciumkonzentration im Harn)]. The calcium levels in the blood and urine should be monitored in these patients.
  • In patients who suffer from sarcoidosis, the medicine should only be used with caution, since the risk of increased conversion of vitamin D insists into its active shape. The calcium levels in the blood and urine should be monitored in these patients.

 

• Wateriness and operating machines
  • There are no special precautions required.

Pregnancy

• Pregnancy and breast feeding period
  • During pregnancy, the medicine should only be taken after a strict indication and only dosed as it is absolutely necessary to fix the defect. Overdoses of vitamin D during pregnancy must be prevented because long-lasting hypercalcemia (increased calcium concentration in the blood) can lead to physical and intellectual disabilities as well as congenital heart and eye diseases of the child.
  • If you are pregnant, you should contact your doctor before taking the drug.
  • The drug should only be taken during breastfeeding if there is a deficiency. Vitamin D and its metabolic products pass into breast milk. An overdose in the infant generated in this way has not been observed.
  • If you breastfeed your child, you should contact your doctor before taking the drug.
    

Hints

Calcium D3 STADA® 1000 mg/880 I.E. Breamer tablets
Active ingredients: calcium carbonate/cholecalciferol (vitamin D3). To compensate for a simultaneous calcium and vitamin D deficiency in older people. To support specific osteoporosis treatment in patients with proven or high risk of simultaneous calcium and vitamin D deficiency. Contains lactose, sodium, hydrated soybean oil and sucrose.
Read the package supplement and ask your doctor or pharmacist for risks and side effects.
Registration holder: STADAPHARM GmbH, Stadastraße 2–18, 61118 Bad Vilbel
Sales: STADA Consumer Health Deutschland GmbH, Stadastraße 2–18, 61118 Bad Vilbel
As of: July 2020

Manufacturer:  STADA GmbH, Stadastraße 2-18, 61118 Bad Vilbel